Champions Oncology (CSBR) EBIT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBIT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -101.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -18.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -465.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 224.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 4,868.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -14,185.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 108.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -21.83 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -744,940.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 108.00 |
| Apr 30, 2026 | 1,247.00 |
| Jan 31, 2026 | -2,807.00 |
| Oct 31, 2025 | -420.00 |
| Jul 31, 2025 | -1,322.00 |
| Apr 30, 2025 | -1,431.00 |
| Jan 31, 2025 | 4,785.00 |
| Oct 31, 2024 | 2,232.00 |
| Jul 31, 2024 | 2,977.00 |
| Apr 30, 2024 | 1,735.00 |
| Jan 31, 2024 | -220.00 |
| Oct 31, 2023 | -1,694.00 |
| Jul 31, 2023 | -1,825.00 |
| Apr 30, 2023 | -1,687.00 |
| Jan 31, 2023 | -2,553.00 |
| Oct 31, 2022 | -218.00 |
| Jul 31, 2022 | -51.00 |
| Apr 30, 2022 | 372.00 |
| Jan 31, 2022 | -279.00 |
| Oct 31, 2021 | 216.00 |